FDA

Subscribe to FDA via RSS
Capsules in packaging process

President Trump’s executive orders and legislative proposals from Congress leverage FDA to help lower drug prices, address anti-competitive practices, and accelerate generic drug approvals.

By J. Benneville (Ben) Haas and William A. McConagha

President Trump signed two executive orders in the last few months aimed at reducing prescription drug costs and addressing drug pricing strategies. On April 15, 2025, he signed an executive order titled “Lowering Drug Prices by Once Again Putting Americans First” in an effort to deliver on…

Genetic Research, A human sample being pipetted into a petri dish for genetic analysis sitting on DNA sequence

Recent developments include leadership changes, workforce reductions, and policy shifts at HHS and FDA, reshaping agency operations under President Trump’s administration.

By Nathan A. Beaton, Jennifer L. Bragg, William A. McConagha, and Trevor Thompson

Since his inauguration, President Trump has focused on reshaping federal agencies through a series of executive orders intended to reduce the size of the federal workforce and dramatically alter the landscape in which agencies operate. In turn, Department of Health and Human Services…

GettyImages-960085942

New rounds of cuts and organizational shifts for HHS staff and operating divisions could dramatically impact the healthcare and life sciences industry.

By Nathan A. Beaton, Joseph C. Hudzik, Elizabeth M. Richards, and Anton Lesaca

On April 1, 2025, the US Department of Health and Human Services (HHS) began implementing a significant reduction in force (RIF) of staff, five days after HHS Secretary Robert F. Kennedy, Jr. announced plans for a “dramatic restructuring” of the department and…

Supermarket aisles with variety of products

The future of GRAS: FDA considers new rules that could impact food product innovation.

By William A. McConagha, Meryl Bartlett, and Trevor Thompson

On March 10, 2025, Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced in a press release that he has directed the Food and Drug Administration (FDA) to explore rulemaking to implement a seismic shift in how most companies introduce ingredients into the nation’s food supply. The shift would eliminate the…

iStock_72624071_Pharmaceutical capsule detail

Latham lawyers discuss how recent developments may impact FDA approval and enforcement activities, including with respect to novel tobacco and nicotine products.

The initial months of the Trump administration have been marked by a flurry of executive orders and activity by the Department of Government Efficiency (DOGE). Those efforts, along with a recent Office of Management and Budget memorandum, may lead to drastic changes at the US Food and Drug Administration (FDA).

In this episode of Connected With Latham…

The Capitol at Night

It remains unclear the extent to which the order will impact agencies like FDA.

By John R. Manthei, Elizabeth M. Richards, Trevor Thompson, and Maya Frost-Belansky*

On February 11, 2025, as part of an ongoing effort to reduce the size of the federal workforce, President Trump issued an executive order titled “Implementing the President’s ‘Department of Government Efficiency’ Workforce Optimization Initiative” (the Order). Elon Musk, who oversees the Department of Government Efficiency (DOGE), addressed questions from…